Introduction
Lung cancer is one of the most common malignancies and the leading cause of cancer-related death worldwide. 1 In China, it is estimated that in 2015 there were 733,300 newly diagnosed lung cancer patients and 610,200 lung cancer deaths, being the top one of all the cancers. 2 Although cigarette smoking remains the major cause of lung cancer, more than half of lung cancer patients are not current smokers, and 15% are lifelong never smoker, suggesting the important role of genetic background in lung cancer. Genome wide association studies (GWAS) have been successful in identifying genomic regions with robust evidence of associations with lung cancer. One of these regions, represented by TERT and CLPTM1L genes which are located at chromosome 5p15.33, was consistently showed strong associations with lung cancer in European and Asian populations, and recently reported to be associated with lung cancer in AfricanAmericans.
TERT encodes the catalytic subunit of telomerase reverse transcriptase. Telomerases are highly specialized chromatin structures that have crucial roles in various cellular processes, such as chromosomal stability and cell growth. 11 Overwhelming evidence suggests that telomere dysfunction, mediated by telomerase activation, promotes malignant transformation of normal cells.
12 CLPTM1L (alias CRR9) encodes the cleft lip and palate-associated transmembrane 1 like protein.
CLPTM1L appears to play a role in apoptosis and cytokinesis, and is overexpressed in lung cancer and required for KRAS driven lung cancer. 13, 14 Single nucleotide variants (SNVs) within TERT-CLPTM1L region has also been reported to be associated with lung cancer risk in never-smokers, 7 and strongly associated with adenocarcinoma. 6 A recent metaanalysis across multiple cancers (including lung cancer) in 34,248 cases and 45,036 controls further provided strong support for extensive pleiotropic genetic effects across this region of 5p15.33. 15 Despite accumulating evidence for the importance of TERT-CLPTM1L, the underlying causal mechanisms are largely unknown. Fine-mapping of this region is required to survey the possible variants for further follow-up studies to understand the biological basis. Recently, a fine-mapping study based on targeted deep sequencing was performed for 5p15.33 region in Europeans and identified novel lung cancer and adenocarcinoma susceptibility loci with large effects. 16 However, the four loci reported in this study (rs139852726, rs61748181, rs138895564 and rs112290073) were not polymorphic among Asians. Together with previous observations that the allelic frequencies of lung cancer risk SNVs identified in Europeans were very low [minor allele frequency (MAF) < 0.05] 17, 18 or not polymorphic 4 among Asian populations, there are genetic heterogeneity in lung cancer susceptibility between populations of European descent and Asians. Therefore, it is possible that variants identified in populations of European descent might not be applicable among Asians because of underlying genetic heterogeneity (both allelic and locus heterogeneity). However, no fine mapping study of TERT-CLPTM1L region in Asians has been reported until now.
In this study, we aimed to explore novel genetic variations in TERT-CLPTM1L region that are associated with lung cancer susceptibility in Han Chinese. To accomplish this, we conducted a two-stage fine-mapping analysis discovered by targeted resequencing 200 lung cancer cases and 300 controls individually, and validated in multiple GWAS data sets with 12,843 lung cancer cases and 12,639 controls.
Materials and Methods

Studies and participants
DNA samples from 200 lung cancer cases and 300 controls were used for targeted resequencing. Lung cancer cases were incident lung cancer patients and consecutively recruited between 2003 and 2012 from the Cancer Hospital of Jiangsu Province, and the First Affiliated Hospital of Nanjing Medical University, Nanjing, China. All of the cases were histopathologically or cytologically confirmed non-small cell lung cancer (NSCLC) without prior history of other cancers or previous chemotherapy or radiotherapy. Controls were selected from individuals receiving routine physical examinations in local hospitals or participating in a community-based screening program for non-infectious diseases conducted in Jiangsu province during the same period when the cases were recruited. The controls were frequency matched to the cases on age (65 years) and gender. Participants were unrelated Han Chinese and were face-to-face interviewed by trained interviewers to collect information on demographic data and smoking status. Individuals who smoked one cigarette per day for >1 year were defined as ever smokers, otherwise they were considered as never smokers. Five-ml of venous blood was collected from each subject after the interview. The targeted resequencing analysis was approved by the institutional review board of Nanjing Medical University (NJMU). Informed consent was obtained from each subject at recruitment.
The samples for validation stage, from the one used in our previous GWAS scan stage (NJMU GWAS), included 2,331 lung cancer cases and 3,077 controls from Nanjing and Beijing; 19, 20 and additional 10,512 lung cancer cases and 9,562 controls from the Female Lung Cancer Consortium in Asia (FLCCA) 8 and the National Cancer Institute [NCI] GWASs 6 were obtained via the database of Genotypes and Phenotypes (dbGAP). The details of these studies were described elsewhere. In brief, The FLCCA (dbGaP Study Accession: phs000716.v1.p1) investigated the etiology of lung cancer among never-smoking women in Asia, including 5,510 lung cancer cases and 4,544 controls from 14 studies from mainland China, South Korea, Japan, Singapore, Taiwan What's new? While cigarette smoking continues to be the leading cause of lung cancer deaths in China, nearly one-sixth of patients have never smoked. Genetic factors likely influence lung cancer susceptibility in these individuals, and of particular interest are variants in TERT and CLPTM1L, genes located on chromosome 5p15. 33 , that appear to be linked to lung cancer in diverse populations. In this fine-mapping analysis of 5p15.33 in Han Chinese, two novel variants, one in TERT and the second in CLPTM1L, were identified and associated with lung cancer susceptibility. The variants were validated in genome-wide association studies in Asians and Europeans.
and Hong Kong. 8 Of these study subjects, 4,922 lung cancer cases and 3,959 controls are available in dbGAP. The NCI GWASs (dbGaP Study Accession: phs000336.v1.p1) were drawn from one population-based case-control study and three cohort studies specifically: the Environment and Genetics in Lung Cancer Etiology (EAGLE) (dbGaP Study Accession: phs000093.v2.p2), 21 the Alpha-Tocopherol, BetaCarotene Cancer Prevention Study (ATBC), 22 the Prostate, Lung, Colon, Ovary Screening Trial (PLCO) 23 Because only EAGLE had information of smoking status, we separated EAGLE as an independent data set, and combined ATBC, PLCO and CPS-II as another. These studies were approved by the individual institutional review boards of each location, and each subject gave informed consent for participation. Lung cancer cases were included based on a lung cancer diagnosis established on clinical criteria and confirmed by pathology reports from surgery, biopsy, or cytology samples in approximately 95% of cases and on clinical history and imaging for the remaining 5%. We obtained the data of EAGLE study including 1,945 cases and 1,992 controls and the data of the other three studies including 3,782 cases and 3,840 controls.
Quality control and imputation of GWAS data sets
The NJMU GWAS was conducted using Affymetrix Genome-Wide Human SNP Array 6.0 with standard quality-control procedures conducted prior to the association analysis. 19, 20 Though the data sets from the dbGaP were described to be deposited after the initial quality control, we performed standard quality control on these data sets. We excluded individuals with low call rates (95%), familial relationships and extreme heterozygosity rates, and removed SNPs with low call rates (95%), MAFs <0.05 and p < 1 3 10 26 for the Hardy-Weinberg equilibrium. For the FLCCA GWAS, we also excluded the overlapped subjects between FLCCA GWAS and NJMU GWAS. As a result, 4,796 cases and 3,741 controls from FLCCA, 1,937 cases and 1,984 controls from EAGLE, 3,779 cases and 3,837 controls from ATBC & PLCO & CPS-II remained after quality control. GWAS genotyping data were imputed for the NJMU, FLCCA and NCI GWASs for >20 million SNPs using data from the 1000 Genomes Project (the Phase III integrated variant set release, across 2,504 samples) as a reference. We phased the haplotypes with Shapeit v2 (http:// www.shapeit.fr/, Phasing step) and performed imputations Derived from the GCTA joint regression model, with adjustment for age, sex and smoking status. 2 Derived from the fixed-effect meta-analysis of the NJMU and FLCCA studies. 3 Derived from the fixed-effect meta-analysis of the EAGLE, ATBC, CPSII and PLCO studies.
Abbreviations: Ref: reference allele; Eff: effect allele; EAF: effect allele frequency.
with IMPUTE2 (http://mathgen.stats.ox.ac.uk/impute/ impute_v2.html). Poorly imputed SNPs defined by an information measure Is < 0.40 with IMPUTE2 were further excluded from the analysis.
Targeted resequencing
Variants for fine-mapping were identified through a targeted resequencing of 200 lung cancer cases and 300 controls individually. Each sample was arranged into four 12 3 12 matrices, enriched for DNA from a 147-kb region in 5p15.33 and captured using custom probes and Agilent Technologies SureSelect Target Enrichment Platform (Agilent Technologies, Santa Clara, CA). Raw image files were filtered using the FASTQ Quality Filter tool. Sequencing was performed at Illumina Genome Analyzer IIx for each sample with a read length of 150 bp. The 126 bp reads were aligned to the human genome reference sequence (hg19) using BurrowsWheeler Aligner (BWA) V.0.5.9. Duplicates were marked using Picard Tools (V.1.95), and the base qualities were recalibrated using Genome Analysis Toolkit (GATK, V.1.0.5974). Variants were called using both GATK and Freebayes, and considered only variants identified by both tools. A total of 1,940 variants [1,880 SNVs and 60 insertions/deletions (INDELs)] were identified through this resequencing. For quality control, we excluded 22 samples with low depth (<10 3) and 8 samples having inconsistent genotypes' distributions of overlapped SNVs with NJMU GWAS (consistent rate <90%). We filtered out 1 SNV having inconsistent genotypes' distribution compared with NJMU GWAS (consistent rate <90%), 4 SNVs with call rate < 90% and 113 SNVs with p for Hardy-Weinberg equilibrium (HWE) < 1.0 3 10 24 either in cases, controls or all subjects (Supporting Information Fig. S1 ). It remained us a total of 192 cases and 278 controls with 1,822 SNVs in the analysis of the target resequencing. Among them, 344 SNVs were common (MAF 0.05 in controls) and 1,479 were rare (MAF < 0.05 in controls). 27% (93 common variants) of the 344 common variants were not included in the 1000 Genomes Project, and the other 251 common SNVs that were identified in the 1000 Genomes Project were included in the final analysis. We applied a series analysis to verify the variants (both common and rare variants) that are not included in the 1000 Genomes Project before association analysis. First, we applied the Integrative Genomics Viewer (IGV) to filter out variants with either less than 310 read depth or up to 20% low quality reads. It remained us 32 of the 93 common variants for further analysis. 26 out of the 32 variants were included in the dbSNP Human Build 141. We then randomly selected 2 variants for Sanger sequencing verification and both variants were confirmed (Supporting Information Fig. S2 ). Among the 1479 rare variants, 63.89% (955 rare variants) have not been reported in 1000 Genomes Project. Using the same strategy, 74.03% (707 rare variants) of the 955 rare variants passed the quality control of IGV. 339 of the 707 variants were included in the dbSNP Human Build 141. Further Sanger sequencing verification also confirmed the randomly selected 2 rare variants (Supporting Information Fig. S2 ).
Functional annotation of the genetic variants from the targeted resequencing was performed using the software Gemini (V.0.18.3) and snpEff (V.3.6). The associations between each variant and lung cancer risk were calculated using logistic regression model with adjustment for age, sex and smoking statue in PLINK (V.1.07). Conditional analysis was performed using an approximated joint regression model in GCTA 25 to select index variants in 5p15.33 region, and those with nominal evidence of association (p < 0.05) were selected for further validation in multiple GWAS data sets.
Validation of identified SNVs
We validated the SNVs identified in targeted resequencing using multiple lung cancer GWASs in both Asian and European populations. Association analysis was performed using SNPTEST v2.5 under a probabilistic dosage model with adjustment for age, sex, smoking pack-year and the first principal component (PCA) in NJMU GWAS, age in FLCCA GWAS, age, sex, smoking status and the first PCA in EAGLE GWAS, and age, sex and the first PCA in ATBC & PLCO & CPSII GWASs. The effect estimates and p values of candidate SNVs in each GWAS data set were then combined using SNPTEST separately by Asian and European populations. Finally, random-effects and fixed-effect meta-analysis were conducted to assess pooled genetic effects in the validation stage. The Cochran's Q statistic and I 2 were calculated using STATA software (V.8.0, College Station, TX) to test the heterogeneity between studies. General analyses were performed with R software (version 3.1.1; The R Foundation for Statistical Computing). p < 0.05 was used as the criterion of statistical significance and all statistical tests were two sided.
In silico analysis and functional annotation
To explore the functional relevance of the identified SNVs, we analyzed the Encyclopedia of DNA Elements (ENCODE), the Roadmap Epigenomics Project database as implemented in RegulomeDB (http://regulomedb.org/) 26 and HaploReg v4.1 (http://www.broadinstitute.org/mammals/haploreg/haploreg.php). 27 We also used Genotype-Tissue Expression (GTEx) project (http://www.gtexportal.org/) for expression quantitative trait loci (eQTL) information for associated SNVs.
Measurement of telomere length
Telomere length was measured in genomic DNA extracted from leukocytes of peripheral blood according to a modified quantitative PCR protocol on an ABI PRISM 7900HT Sequence Detection System (Applied Biosystems) as described previously. 28 In brief, relative telomere length (RTL) were determined by the ratio of telomere repeat copy number (T) to single-copy gene copy number (S) and expressed as T: S ratio in individual samples relative to a reference of DNA pool from five healthy donors. The reference DNA was firstly used to generate a standard curve with concentrations ranging from 0.25 to 8 ng/ml, and linearity (r 2 > 0.99) over this range of input DNAs was observed. Samples with threshold cycle (Ct) numbers that fell outside the range defined by the standard curves were rerun at a different concentration to ensure that they were amplified within the linear range. The primer sequences for telomere and single-copy gene (36B4) quantitative PCR (qPCR) amplification are listed in Supporting Information Table S1. Reference pooled DNA was then assayed in each 384-well plate to account for between-plate variation. Each well contained 10 ml SYBRV R Green PCR Master Mix (Applied Biosystems) with a final DNA concentration of 5 ng/ml. All samples were run in duplicates and the mean Derived from the fixed-effect meta-analysis of the NJMU and FLCCA studies. 2 Derived from the fixed-effect meta-analysis of the EAGLE, ATBC, CPSII and PLCO studies. 3 Derived from the fixed-effect meta-analysis of the NJMU, FLCCA, EAGLE, ATBC, CPSII and PLCO studies. 4 Derived from the random-effects meta-analysis of the NJMU, FLCCA, EAGLE, ATBC, CPSII and PLCO studies. P for heterogeneity. 4 P for interaction analysis.
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Fine mapping of chromosome 5p15.33 in Han Chinese of two measurements was used in the statistical analyses. 29 The CV of the two measurements was 0.38% and 0.29% for the telomere reaction and the single-copy gene reaction, respectively. Technicians were blinded to the case-control status. RTL was calculated according to Cawthon's formula, 2 2(DCt1-DCt2) 5 2 2DDCt . The inter-plate variation of the quality control samples for RTL measurement was 10.16% and the intraplate variation was 8.69%.
Results
The demographic characteristics of the study population were shown in Supporting Information Table S2 . We produced a total of 470 next-generation Illumina sequencing libraries from the 192 lung cancer cases and 278 controls. Among cases, 73% were male and 67% were smokers. The coverage for targeted resequencing was 88.4% for 5p15.33 region and the average depth is 99.03 3.
Of the 251 variants that were analyzed, 25 were significantly associated with lung cancer risk at p values <0.05, including previously reported risk variants by GWASs, such as rs2736100, rs2853677 and rs401681 (Supporting Information Table S3 ). To delineate distinct association signals arising from multiple variants in the same region, we applied approximate conditional analysis with GCTA joint regression model. Five novel independent SNVs were identified: rs10054203 in TERT (OR 5 1.69, p 5 2.70 3 10 (Table   1 and Fig. 1 ).
To validate the associated SNVs identified by targeted resequencing, we performed association analysis in multiple lung cancer GWASs separately by Asian and European population. Two of the five SNVs were replicated in both Asian and European populations (Table 1) Table 2 ). Combined all validation samples together using random-effects model and fixed-effect model, similar effect size was observed (OR 5 1.21 and 1.20, respectively, for rs10054203; and OR 5 0.83 and 0.82, respectively, for rs397640); however, the p values was dramatically increased. Based on the linkage disequilibrium (LD) in this region, rs397640 was in the same LD block with previous reported risk variants rs402710, rs401681, rs465498 and rs31489 (r Fig. S3 ). We applied conditional analysis to test the independence of rs10054203 and rs397640 and used the predefined variants as covariate. As expected, after conditioning on the previously reported associated SNVs in this region, denoted by rs2736100 and rs401681, the associations observed for rs10054203 and rs397640 were largely attenuated (p Conditional 5 0.07 and 0.04 for rs10054203 and rs397640, respectively) (Table 3) . Notably, conditioning on rs10054203 and rs397640, the GWAS SNVs were no longer significant in Figure 2 . eQTL analysis for rs10054203 in lung tissues.
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the targeted resequencing analysis (all p Conditional > 0.05, Supporting Information Table S4) .
We then performed stratification analysis of rs10054203 and rs397640 by age, gender and smoking status using targeted-resequencing data (Table 4) . For rs10054203, a stronger association was observed in older participants, female, and never smokers, while for rs397640, a stronger association was observed in younger subjects, male and ever smokers. No statistically significant interactions between genetic effects and age, gender or smoking status were observed. However, stratification analysis using GWAS data of Asian population further revealed statistically significant interactions between rs10054203 and gender and smoking status (p for interaction 50.013 and 0.004 for sex and smoking status, respectively, Table 5 ).
Bioinformatic analyses using public data bases (ENCODE and Roadmap Epigenomics Project database) were performed to investigate the possible regulatory function of rs10054203 and rs397640. Based on ENCODE data, the evidence for putative regulatory functions of these two SNVs was observed with regulatory histone modification marks and/or DNase I hypersensitivity peaks in multiple cell types. We used GTEx databese to estimate the eQTLs for lung cancer and found the risk allele (C) of rs10054203 was significantly associated was lower mRNA expression of CTD-2245E15.3 (p 5 0.019) and Tubulin Polymerization-Promoting Protein (TPPP, p 5 0.031) in 167 lung tissues (Fig. 2) .
We further evaluated the correlation between the two newly identified variants and the telomere length (TL) among 1,012 cancer-free subjects. However, neither of these two variants showed statistically significant associations with TL (p 5 0.122 and 0.504 for rs10054203 and rs397640, respectively) (data not shown).
Discussion
Chromosome 5p15.33 harbors a unique lung cancer susceptibility region that contains at least two plausible candidate genes: TERT and CLTPM1L. In this fine-mapping analysis, we have characterized common genetic variants for 5p15.33 associated with lung cancer risk in Chinese population by sequencing 147 kb on TERT-CLTPM1L region. We identified two novel genetic variants (rs10054203 and rs397640) that were associated with lung cancer risk in Chinese population and consistently validated in large-scale GWAS data sets in both Asian and European populations.
Both TERT and CLPTM1L are attractive candidate genes for lung cancer as they have both been plausibly linked with carcinogenesis. TERT encodes the catalytic subunit of the telomerase reverse transcriptase, which, in combination with an RNA template (TERC), adds nucleotide repeats TTAGGG to chromosome ends. 30 The telomerase is responsible for telomere regeneration, and up to 90% of human tumor samples, including lung cancer, show telomerase activity, 31, 32 indicating that regeneration of telomeres is crucial for most forms of carcinogenesis. It has been shown that TERT expression is not detectable in most normal tissues while high in cancer cells. Specifically, in lung cancer, TERT gene expression, activity, and gene copy number are significantly increased in lung cancer cells. 32 In addition, telomeres may drive tumor progression and metastasis by activating the glycolytic pathways. 33 The most commonly reported variant in the TERT gene, rs2736100, was first identified in lung cancer GWAS in European, 3 and consistently replicated in other European populations, [4] [5] [6] Asians 7-9,18,19 and African-Americans. 10 The variant rs2736100 was also strongly associated with lung cancer risk in never smokers and adenocarcinoma. [6] [7] [8] [9] The novel variant identified in the current study, rs10054203, was located in the intron region of TERT and 6 kb away from rs2736100 (r 2 5 0.56, D'50.76). A conditional analysis demonstrated that the effects of all GWAS SNVs were abolished or substantially reduced by rs10054203, including rs2736100, suggesting that these variants may represent the same causal variants. Interestingly, based on ENCODE data, rs10054203 showed evidence of the DNase I hypersensitivity site (DHS) and regulatory histone modification marks H3K27Ac, H3K36M3 and H3K27Me3 in multiple cell types, suggesting a possible regulatory function for rs10054203 as the H3K27Ac is thought to enhance transcription possibly by blocking the spread of the repressive histone mark H3K27Me3. In the eQTL analysis using GTEx Portal (http:// www.gtexportal.org/home/), we found the rs10054203 C allele was significantly associated with lower mRNA expression of CTD-2245E15.3 and TPPP in lung tissues. CTD-2245E15.3 is an lncRNA downstream of TERT. Although the biological function of CTD-2245E15.3 is still unknown, lncRNA has been shown to be involved in many fundamental biological functions, and dysregulation of lncRNA may contribute to the development and progression of human malignancies, especially lung cancer. 34 TPPP is expressed in brain and neuroblastoma cells, and promotes tubulin assemblies and blocks mitotic spindle formation. 35, 36 Experimental studies have reported that increased genomic copy number of TPPP was associated with progression of bladder cancer, 37 and was the most frequent genetic event in early stages of NSCLC. 32 In addition, the association between rs10054203 and lung cancer risk was much stronger in Asian than in Caucasian population. This racial genetic heterogeneity may be caused by different genetic background such as different patterns of LD in this region. Together, the effect of rs10054203 may be complicated, and additional studies are warranted to clarify the underlying mechanisms.
CLPTM1L encodes an enzyme, cleft lip and palate transmembrane 1-like that is upregulated in lung cancer tissues and may be associated with anti-apoptotic mechanism which affects the resistance to chemotherapy. 38 Experimental studies also showed that CLPTM1L promotes growth and survival, and is required for KRAS driven lung cancer. 14, 38 Genetic variants within the CLPTM1L have been found to be associated with the accumulation of DNA adducts in tumor adjacent lung tissue 39 and contribute to the susceptibility of lung cancer in multiple GWASs. 3, 4 In the current study, we identified an intronic variant in CLPTM1L, rs397640, was associated lung cancer risk. Rs397640 was in the same LD block with rs401681 (r 2 50.16, D'50.95), a lung cancer associated SNV identified in multiple GWASs. 3, 4 The association observed for rs397640 was slightly attenuated but remained statistical significant after accounting for rs401681 (p 5 4.0 3 10
22
), whereas conditioning on rs397640, the association for rs401681 was vanished (p 5 0.2), suggesting rs397640 may be independent of rs401681 and a yet unknown variant in this block may underlie the causation of lung cancer. In silico analysis through the ENCODE database indicated the potential regulatory function of rs397640 as evidenced by its position at the peak region of histone modification marks H3K27Ac, H3K36M3 and CTCF in multiple cell lines. However, these results are preliminary and warrant further investigations.
Increasing studies have reported genetic variants at TERT locus were associated with telomere length and risk of various cancers, including lung, breast and ovarian cancers. [40] [41] [42] Some variants regulated the risk of cancers via altered telomere length, and some not. For example, a prospective cohort study of smoking males in Finland recently reported that longer telomere length was associated with increased risk of lung cancer, and rs2736100 G allele was associated with longer telomere length. 40, 42 Bojesen et al. reported that rs2736108 was associated with lower risks for estrogen receptor (ER)-negative breast cancer via being associated with longer telomeres, while rs10069690 and rs2242652 did not. 41 In the current study, we did not observe any significant associations between rs10054203 and rs397640 and telomere length, indicating these two SNVs may regulate lung cancer susceptibility not via altering telomere length. Further study with large sample size in diverse populations and functional work is needed to verify our findings.
In summary, the current analysis represents the largest and first resequencing-based fine-mapping analysis of 5p15.33 region in Han Chinese. Limited by the small sample size of targeted resequencing, we chose to use conventional statistical significance to include all promising signals for further validation in large-scale multiple-ethnic GWAS data, and identified two novel SNVs associated with lung cancer. As 5p15.33 region showing relatively little common genetic variants due to strong evolutionary constraint, additional studies are needed to investigate rare variants (MAF < 0.05). Further validation studies and functional studies are also required to confirm the roles of the newly discovered variants.
